Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 326-330

  Banerjee, Dilip K ^a   Mcdermott Lancaster, R Denise ^a   Mckenzie, Sandra ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; DAPSONE; LEPROSTATIC AGENT; MINOCYCLINE; OFLOXACIN; RIFAMPICIN; SPARFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; LEPROSY; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031039938     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.326     Document Type: Article

References (23)

1. Banerjee, D. K., and R. D. McDermott-Lancaster. 1992. An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection. Int. J. Lepr. 60:410-415.
2. Blanc, L., P. Jamet, O. Faye, S. Sow, and P. Bobin. 1993. Short-term rifampicin-containing regimens for MB leprosy lead to high risk of relapse. Int. J. Lepr. 61:7A.
3. Chan, G. P., B. Y. Garcia-Ignacio, V. E. Chavez, J. B. Livelo, C. L. Jimenez, M. L. R. Parilla, and S. G. Franzblau. 1994. Clinical trial of clarithromycin for lepromatous leprosy. Antimicrob. Agents Chemother. 38:515-517.
4. Chan, G. P., B. Y. Garcia-Ignacio, V. E. Chavez, J. B. Livelo, C. L. Jimenez, M. L. R. Parilla, and S. G. Franzblau. 1994. Clinical trial of sparfloxacin for lepromatous leprosy. Antimicrob. Agents Chemother. 38:61-65.
5. Colston, M. J., G. R. F. Hilson, and D. K. Banerjee. 1978. The "proportional bactericidal test," a method for assessing bactericidal activity of drugs against Mycobacteriutn leprae in mice. Lepr. Rev. 49:7-15.
6. Fajardo, T. T., L. G. Villahermosa, E. C. dela Cruz, R. M. Abalos, S. G. Franzblau, and G. P. Walsh. 1995. Minocycline in lepromatous leprosy. Int. J. Lepr. 63:8-17.
7. Franzblau, S. G., M. L. Parilla, and G. P. Chan. 1993. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice. Int. J. Lepr. 61:66-69.
8. Gelber, R. H. 1987. Activity of minocycline in Mycobacterium leprae-infected mice. J. Infect. Dis. 186:236-239.
9. Gelber, R. H. 1993. Activity of minocycline and aminoglycosides against Mycobacterium leprae. Int. J. Lepr. 61:314-315.
10. Gelber, R. H., L. P. Murry, P. Siu, M. Tsang, and T. H. Rea. 1994. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy. Int. J. Lepr. 62:568-573.
11. Gelber, R. H., A. Iranmanesh, L. Murray, P. Siu, and M. Tsang. 1992. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice. Antimicrob. Agents Chemother. 36:2544-2547.
12. Grosset, J. H., C. C. Guelpa-Lauras, E. G. Perani, and C. Beoletto. 1988. Activity of ofloxacin against Mycobacterium leprae in the mouse. Int. J. Lepr. 56:259-264.
13. Grosset, J. H., B. Ji, C. C. Guelpa-Lauras, E. G. Perani, and L. N'Deli. 1990. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. Int. J. Lepr. 58:556-561.
14. Halvorson, H. O., and N. R. Ziegler. 1933. Application of statistics to problems in bacteriology. I. A means of determining bacterial population by the dilution method. J. Bacteriol. 25:101-121.
15. Hastings, R. C., and S. K. Chehl. 1991. Chemotherapy of leprosy in multibacillary nude mice. Int. J. Lepr. 63:350-351.
16. Holmes, I. B., and G. R. F. Hilson. 1972. The effect of rifampicin and dapsone in experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action. J. Med. Microbiol. 5:251-261.
17. Ji, B., E. G. Perani, C. Petinom, and J. H. Grosset. 1992. Bactericidal activities of a single or multiple doses of various combinations of new antileprosy drugs and/or rifampicin against M. leprae in mice. Int. J. Lepr. 60:556-561.
18. Ji, B., E. G. Perani, and J. H. Grosset. 1991. Effectiveness of clarithromycin and minocycline alone and in combination against Mycobacterium leprae infection in mice. Antimicrob. Agents Chemother. 35:579-581.
19. Ji, B., P. Jamet, E. G. Perani, P. Bobin, and J. H. Grosset. 1993. Powerful bactericidal activities of clarithromycin and minocycline in the treatment of lepromatous leprosy. J. Infect. Dis. 168:188-190.
20. Ji, B., E. G. Perani, C. Petinom, and J. H. Grosset. 1996. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob. Agents Chemother. 40:393-399.
21. McDermott-Lancaster, R. D., and D. K. Banerjee. 1993. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test. Int. J. Lepr. 61:605-608.
22. McDermott-Lancaster, R. D., and G. R. F. Hilson. 1987. Rifampicin-resistant M. leprae may have reduced virulence. J. Med. Microbiol. 24:13-15.
23. Workshop on the Elimination of Leprosy. 1993. 14th ILA Congress, Orlando. Int. J. Lepr. 61:753.